ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.410
-0.120 (-4.74%)
Dec 5, 2025, 4:00 PM EST - Market closed
ABVC BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 57 | 7 | 9 | 20 | 96 | 105 | |
| Market Cap Growth | 735.36% | -19.29% | -55.74% | -78.95% | -8.30% | 24.82% | |
| Enterprise Value | 59 | 9 | 12 | 22 | 95 | 109 | |
| Last Close Price | 2.41 | 0.59 | 1.16 | 6.25 | 33.90 | 51.00 | |
| PS Ratio | 52.03 | 14.18 | 58.72 | 20.85 | 269.96 | 216.85 | |
| PB Ratio | 4.69 | 9.98 | 7.14 | 6.25 | 10.83 | 39.35 | |
| P/TBV Ratio | 4.71 | 5.89 | 5.76 | 6.53 | 10.86 | 30.46 | |
| EV/Sales Ratio | 73.97 | 18.41 | 80.24 | 22.60 | 266.23 | 225.32 | |
| Debt / Equity Ratio | 0.17 | 4.41 | 2.21 | 1.06 | 0.38 | 2.54 | |
| Asset Turnover | 0.05 | 0.07 | 0.02 | 0.08 | 0.03 | 0.05 | |
| Inventory Turnover | - | - | - | - | 0.39 | - | |
| Quick Ratio | 0.04 | 0.05 | 0.03 | 0.18 | 1.72 | 0.97 | |
| Current Ratio | 0.63 | 0.33 | 0.27 | 0.54 | 2.07 | 1.27 | |
| Return on Equity (ROE) | -47.71% | -531.91% | -368.89% | -269.48% | -208.73% | -835.04% | |
| Return on Assets (ROA) | -17.22% | -38.38% | -48.71% | -81.16% | -57.83% | -57.36% | |
| Return on Capital (ROIC) | -22.17% | -74.08% | -79.26% | -100.17% | -67.64% | -74.68% | |
| Return on Capital Employed (ROCE) | -33.50% | -478.90% | -402.20% | -374.50% | -117.00% | -125.80% | |
| Earnings Yield | -8.94% | -67.87% | -87.01% | -81.21% | -13.37% | -9.35% | |
| FCF Yield | -4.00% | -25.04% | -47.01% | -37.18% | -7.93% | -4.36% | |
| Buyback Yield / Dilution | -71.54% | -169.26% | -36.92% | -26.39% | -27.07% | -12.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.